The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Risk factors in the HR-NBL-1/SIOPEN study in patients receiving dinutuximab beta (DB) based immunotherapy.
 
Ruth Lydia Ladenstein
Honoraria - Apeiron Biologics; Boehringer Ingelheim; EUSA Pharma
Consulting or Advisory Role - Apeiron Biologics; Boehringer Ingelheim; EUSA Pharma (Inst)
Research Funding - Apeiron Biologics (Inst); EUSA Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Apeiron Biologics (Inst); EUSA Pharma (Inst)
Expert Testimony - Apeiron Biologics; EUSA Pharma
Travel, Accommodations, Expenses - Apeiron Biologics; EUSA Pharma
 
Ulrike Poetschger
No Relationships to Disclose
 
Dominique Valteau-Couanet
Consulting or Advisory Role - EUSA Pharma (Inst)
Research Funding - Orphelia Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Apeiron to SIOPEN (Inst)
Travel, Accommodations, Expenses - EUSA Pharma; Jazz Pharmaceuticals
 
Juliet Gray
No Relationships to Disclose
 
Roberto Luksch
No Relationships to Disclose
 
Walentyna Balwierz
Honoraria - Gilead Sciences; Shire
Consulting or Advisory Role - Amgen; Novartis; Roche
Travel, Accommodations, Expenses - Jazz Pharmaceuticals; Roche; SERVIER; Shire
 
Victoria Castel
No Relationships to Disclose
 
Shifra Ash
No Relationships to Disclose
 
Maja Beck Popovic
No Relationships to Disclose
 
Genevieve Laureys
No Relationships to Disclose
 
Godfrey Chi-Fung Chan
Leadership - Pangenia; Xellera Therapeutics
Consulting or Advisory Role - Pangenia; Xellera Therapeutics
Speakers' Bureau - Pangenia; Xellera Therapeutics
Patents, Royalties, Other Intellectual Property - Pangenia; Xellera Therapeutics
 
Ellen Ruud
No Relationships to Disclose
 
Kim Vettenranta
No Relationships to Disclose
 
Cormac Owens
No Relationships to Disclose
 
Henrik Schroeder
No Relationships to Disclose
 
Peter F Ambros
No Relationships to Disclose
 
Sabine Sarnacki
No Relationships to Disclose
 
Tom Boterberg
No Relationships to Disclose
 
Holger N. Lode
Consulting or Advisory Role - Apeiron Biologics; EUSA Pharma
Research Funding - Apeiron Biologics (Inst); EUSA Pharma (Inst); Roche (Inst)
Travel, Accommodations, Expenses - EUSA Pharma